This is a big deal, Folks! Asante Solutions, maker of the new Snap insulin pump, just signed an agreement to make its data protocols open and available via the new open-source Tidepool Platform. This means that for the first time ever, a pump maker is going straight to the cloud, committing to an open system that will allow users to combine their pump data with CGM data and other records, and view and share that…Read more »
We were so pleased to host two key individuals from the FDA at this year’s DiabetesMine Innovation Summit: Courtney Lias, Director of CDRH/Division of Chemistry and Toxicology (who gave one of the opening talks updating us on FDA progress), and her colleague Stayce Beck, head of the FDA’s artificial pancreas team. Their involvement in this patient-led leadership forum is proof that the ePatient Revolution is changing the dynamics of health and medicine policy!
Our patient community has been up in arms for quite some time about glucose meter accuracy, or rather lack thereof. Fortunately, the patient-initiated StripSafely campaign seems to have struck a chord, and the FDA has recently — at long last — issued new “draft guidance” on accuracy standards. What surprised a lot of people, though, is how FDA chose to split their recommendations into two categories: one set of requirements for meters purchased over-the-counter and…Read more »
Well, we’ve all made it through another year!
Amazing that it’s almost time to turn the page on 2013 and move into 2014… With about a week left, we are about 98% sure we can say that all the big diabetes news of this year has probably materialized already.
There have been some exciting steps forward on long-awaited product developments, from FDA filings to approvals that the Diabetes Community has been anticipating. Not to mention…
John Brooks III is CEO of the legendary Joslin Diabetes Center in Boston. He’s unique as the leader of an academic medical center, in that he has a strong background in industry — having previously co-founded Insulet (makers of the OmniPod) and two other life sciences companies. We interviewed him in Spring about his ambitious plans to spread Joslin’s expertise across the country and around the world. It’s all about utilizing tech innovations in the…Read more »